Netherlands· NL-eca88df41b15
Rytelo 188 mg poeder voor concentraat voor oplossing voor infusie
A imetelstat product containing imetelstat natrium, registered in Netherlands by Geron Netherlands B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Imetelstat is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XX80 (imetelstat), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Imetelstat · ATC L01XX80
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- IMETELSTAT NATRIUM
- Manufacturer
- Geron Netherlands B.V.
- Country
- Netherlands (NL)
- ATC code
- L01XX80
- ATC class
- Imetelstat
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/24/1894
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imetelstat in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRYTELOGeron Corporation
- CzechiaRYTELOGeron Netherlands B.V., Amsterdam
- FinlandRyteloGeron Netherlands B.V.
- IrelandRytelo 188 mg powder for concentrate for solution for infusionGeron Netherlands B.V.
- IcelandRyteloGeron Netherlands B.V.
- BelgiumRytelo 188 mgGeron Netherlands
- PolandRyteloGeron Netherlands B.V.
- SwedenRytelo 188 mg Pulver till koncentrat till infusionsvätska, lösningGeron Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rytelo
- Liechtenstein · Rytelo
- Norway · Rytelo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddc4ea6f-db0e-427b-9702-e0093a547ade GET /v1/drugs/ddc4ea6f-db0e-427b-9702-e0093a547ade?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/rytelo-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Imetelstat",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132269",
"excipients": [
"NATRIUMCARBONAAT 0-WATER (E 500 (I))",
"STIKSTOF (HEAD SPACE) (E 941)",
"ZOUTZUUR (E 507)"
],
"substances": [
"IMETELSTAT NATRIUM"
],
"leaflet_url": null,
"authorised_at": "2025/03/07",
"procedure_number": "EMEA/H/C/006105",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/24/1894",
"additional_monitoring": "Y"
}See everything about imetelstat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.